Arrowhead Pharmaceuticals, Inc. (ARWR) operating KPIs
ARWRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 5/3086% above fair value
$59.90−0.59 (-0.98%)
Close on Oct 30, 2026Market cap $8.46BP/E –Yield –
KPIs
Operating metrics that drive Arrowhead Pharmaceuticals's business
Coming soon
This tab will track the numbers specific to Arrowhead Pharmaceuticals's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.